Table 1.
Characteristics of the participants at baseline, by group. Mean(SD)
| SRTT | Control | p value | |
|---|---|---|---|
| Characteristics | (n = 57) | (n = 29) | |
| Men/women (number) | 30/27 | 15/14 | 0.934 |
| Freezers/Non-freezers (number) | 21/36 | 9/20 | 0.026 |
| Age (years) | 66.9 (9.8) | 65.1 (9.9) | 0.422 |
| Educational level (years) | 11.7 (5.7) | 11.4 (5.6) | 0.795 |
| Body mass (kg) | 70.0 (12.5) | 65.2 (12.1) | 0.110 |
| Height (cm) | 1.6 (0.1) | 1.7 (0.1) | 0.193 |
| Body mass index (kg/m2) | 25.9 (4.6) | 23.9 (5.3) | 0.099 |
| MoCA (score) | 24.5 (2.8) | 24.9 (3.6) | 0.187 |
| Years since diagnosis (years) | 7.6 (5.2) | 8.0 (5.7) | 0.758 |
| Modified Hoehn and Yahr staging scale (a.u) | 2.6 (0.7) | 2.8 (0.6) | 0.359 |
| 1 | 1 | 0 | |
| 1.5 | 1 | 0 | |
| 2 | 20 | 9 | |
| 3 | 31 | 17 | |
| 4 | 4 | 3 | |
| L-Dopa equivalent daily dose (mg/day) | 619.7 (341.3) | 618.1 (451.5) | 0.986 |
| UPDRS-III (score) | 31.8 (17.4) | 33.6 (15.7) | 0.647 |
| Days practicing social distancing (days/week) | 6.4 (1.2) | 6.7 (0.7) | 0.170 |
| Outcomes | |||
| PDQ-39 (%) | 32.3 (13.8) | 33.0 (13.3) | 0.182 |
| Walking from UPDRS-III (score) | 1.3 (0.8) | 1.4 (0.8) | 0.997 |
| Posture from UPDRS-III (score) | 0.9 (1.1) | 1.0 (0.7) | 0.621 |
| NFOGQ (score) | 15.2 (7.1) | 16.5 (7.6) | 0.768 |
SRTT supervised, real-time videoconferencing telerehabilitation, Control nonexercising control group, MoCA Montreal Cognitive Assessment, a.u. arbitrary units, UPDRS-III Unified Parkinson’s Disease Rating Scale part III, PDQ-39 Parkinson´s Disease Questionnaire, NFOGQ New-freezing of gait questionnaire